Physician profile
Robert J Warkala
NPI 1851339659
$11,074.81
in general payments reported to CMS, 2019-2025
22 companies · $652 in 2025
The $652 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,330 · 2020: $2,561 · 2021: $1,565 · 2022: $1,084 · 2023: $937 · 2024: $946 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,534.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $5,831.83 | 2019-2022 | |
| Smith+Nephew, INC. | $967.11 | 2019-2025 | Stravix, Stravix Mesh, Grafix Pl |
| Organogenesis INC. | $811.93 | 2019-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Stryker Corporation | $462.91 | 2019-2023 | Sonicpin, Variax, Ortholoc 2 Lapifuse |
| Abbott Laboratories | $443.59 | 2023-2025 | Proclaim, Eterna, Esprit |
| Depuy Synthes Sales INC. | $421.88 | 2019-2024 | Na, Motoband, Hammerlock |
| Abbvie INC. | $334.61 | 2019-2023 | Dalvance |
| Paratek Pharmaceuticals, INC. | $264.08 | 2023-2025 | Nuzyra |
| Amgen INC. | $262.89 | 2024-2025 | Krystexxa |
| Integra Lifesciences Corporation | $173.17 | 2020-2022 | |
| Medtronic, INC. | $149.58 | 2024 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $147.95 | 2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $144.73 | 2022 | |
| Acell, INC. | $121.49 | 2019 | |
| Ani Pharmaceuticals, INC. | $117.99 | 2024 | Purified Cortrophin Gel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $104.06 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.92 | 2019 | |
| Nevro Corp. | $91.04 | 2023 | Senza |
| Grt US Holding, INC. | $83.30 | 2022 | |
| Kci USA, INC. | $13.93 | 2021 | |
| Averitas Pharma INC. | $13.91 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Warkala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.